Development of varicella during adalimumab therapy.
Lee
D H
DH
Kim
H S
HS
Song
Y W
YW
Cho
K H
KH
D000212:Acyclovir / Q000627:therapeutic use; D000068879:Adalimumab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002644:Chickenpox / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000998:Antiviral Agents; D000068879:Adalimumab; D000212:Acyclovir